Search details
1.
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial.
Eur Heart J
; 44(1): 41-50, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-36254693
2.
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial.
Circulation
; 146(4): 279-288, 2022 07 26.
Article
in English
| MEDLINE | ID: mdl-35377706
3.
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial.
Eur J Heart Fail
; 26(4): 963-970, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38572654
4.
The win ratio method in heart failure trials: lessons learnt from EMPULSE.
Eur J Heart Fail
; 25(5): 632-641, 2023 05.
Article
in English
| MEDLINE | ID: mdl-37038330
5.
Mineralocorticoid receptor antagonist use and the effects of empagliflozin on clinical outcomes in patients admitted for acute heart failure: Findings from EMPULSE.
Eur J Heart Fail
; 25(10): 1797-1805, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37540060
6.
Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial.
Eur J Heart Fail
; 24(10): 1844-1852, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36066557
7.
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial.
Nat Med
; 28(3): 568-574, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35228754
Results
1 -
7
de 7
1
Next >
>>